Search

everythinglearnresearchcommunity

for

Search:↓

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

The session covered updates on skin treatments, including radiotherapy, imiquimod, acitretin, JAK inhibitors, and strategies for managing rosacea and preventing surgical infections.

Finasteride treats enlarged prostate, shrinks it, improves urination, but may cause sexual dysfunction and isn't for women or children.

Men taking 5α-reductase inhibitors for enlarged prostate have a higher chance of experiencing reduced sexual desire and erectile dysfunction.

Ketoconazole cream is effective for skin conditions like seborrheic dermatitis and may help with hair loss and other skin issues, with generally mild side effects.

New treatments for hair loss show promise, especially finasteride for men and a stronger minoxidil formula.

Docetaxel is safe and works well for older people with cancer, with manageable side effects.

Proteasome inhibitors are promising treatments for various cancers, autoimmune diseases, and other conditions.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

JAK inhibitors help with skin conditions but need more research on dosing and safety.

Dutasteride more effectively treats hair loss than finasteride, but may increase risk of altered libido.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

As of 1994, treatments for liver cancer had not significantly improved patient survival.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

Stem cell research and regenerative medicine have made significant advancements in treating various diseases and conditions.

A patient with Alopecia Areata had complete hair regrowth after using the drug baricitinib.

New effective scar treatments are urgently needed due to the current options' limited success.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

Vitamin D has potential benefits for cancer prevention, heart health, diabetes, obesity, muscle function, skin health, and immune function, but clinical results are mixed and more research is needed.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

The document concludes that sexual and psychiatric side effects from 5-alpha-reductase inhibitors are reported, but more high-quality research is needed to understand how often they occur.

New acne treatments show promise as alternatives to traditional therapies.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

The estradiol valerate/dienogest oral contraceptive helps with heavy periods, may improve acne and symptoms in PCOS, and doesn't affect sexual function.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

New treatments for lupus show promise, but more research is needed, especially for children.

Baricitinib shows promise as a new treatment for certain skin conditions like alopecia areata.

New JAK inhibitor drugs show promise for treating skin diseases but need more research on safety and effectiveness.